Tilray Brands, Inc. (TLRY) reached $0.4 at the closing of the latest trading day, reflecting a -2.84% change compared to its last close.

The stock's fall snapped a four-day winning streak.

Tilray Medical has become the first company to receive Italian authorization to distribute medical cannabis flower for ...

Shares of Tilray Brands Inc. TLRY rallied 4.72% to $0.41 Thursday, on what proved to be an all-around positive trading ...

Tilray Brands (NasdaqGS:TLRY) has recently published a scientific study through its medical division, comparing the bioavailability of different cannabinoid formulations. This event, paired with the ...

According to Benzinga Pro, TLRY stock has lost over 76% in the past year. In a separate release, Montauk Brewing Co., a ...

Tilray Medical, a division of Tilray Brands, Inc., today announced the publication of a study that focuses on comparing the ...

New Study Provides Insight into the Bioavailability of Medical Cannabis Formulations for Therapeutic TreatmentNEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, ...

New Study Provides Insight into the Bioavailability of Medical Cannabis Formulations for Therapeutic TreatmentNEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, ...

Tilray Medical has its international cannabis operations in Canada, Portugal, and Germany, and is a leading global medical ...

Tilray Medical has made history as the first company to receive formal authorization from the Italian Ministry of Health to import and distribute its branded medical marijuana flower products across ...

Hot off the press cannabis, marijuana, cbd and hemp news from around the world on the WeedLife Social Network.